Skip to content

Prospective randomised trial using Integusealâ as microbial sealant for arterial bypass surgery on lower extremities

Prospective randomised trial using Integusealâ as microbial sealant for arterial bypass surgery on lower extremities - ITT (Integuseal trial)

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON32841
Enrollment
200
Registered
2009-06-17
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative wound infections

Interventions

Application of a layer of Integuseal (Cyanoacrylate) from a ready to use applicator preoperative before incision. Polymerisation immobilises the bacteries that survived the conventional skin prepara

Sponsors

Alysis Zorggroep
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Planned supragenual of infragenual peripheral arterial bypass procedures with autologue or prosthetic graft

Exclusion criteria

Exclusion criteria: Secundaire procedures and suprainguinal procedures

Design outcomes

Primary

MeasureTime frame
Postoperative woundinfections

Secondary

MeasureTime frame
Costs of the use of Integuseal complications during hospital stay

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)